Meet the editor

Mira Siderova, MD, PhD, is an endocrinologist at the University Hospital "St. Marina" and an Associate Professor of Endocrinology and Metabolic Diseases at the Medical University of Varna. Dr Siderova received her MD, endocrine training, and her doctorate from the Medical University of Varna and was a post-doctoral research fellow at the University of Bari, Italy. In 2015 she was awarded the prize of the Bulgarian Endocrine Society for best

scientific development. She has been involved in teaching and training students, doctors, and PhD candidates in diabetes and endocrinology for the last 9 years. She has authored above 70 publications – original papers and reviews, book chapters, a monograph, and international conference reports. Her main interests are focused on diabetes, obesity, thyroid diseases, and osteoporosis. Dr Siderova is currently an independent expert at the European Commission, Research and Innovation, as well as a member of the European Thyroid Association (ETA), International Osteoporosis Federation (IOF), Bulgarian Society of Endocrinology (BDE), and Union of Scientists in Bulgaria.

Contents

**Section 1**

**Section 2**

**Section 3**

Technology *by Alan B. Schorr*

*and Yatinesh Kumari*

**Preface III**

Pathogenesis of Type 2 Diabetes and Its Complications **1**

**Chapter 1 3**

**Chapter 2 25**

**Chapter 3 43**

Diabetes and the Brain **59**

**Chapter 4 61**

Management of Type 2 Diabetes **73**

**Chapter 5 75**

**Chapter 6 99**

Emerging Role of Pancreatic β-Cells during Insulin Resistance

Oxidative Stress, DNA Damage and Repair Pathways in Patients

*by Jessica E.B.F. Lima, Danilo J. Xavier and Elza T. Sakamoto-Hojo*

*by Faiz Ahmed Shaikh, K.C. Bhuvan, Thet Thet Htar, Manish Gupta* 

*by Maswood M. Ahmad, Imad Addin Brema and Mussa H. Almalki*

Newer Modalities in the Treatment of Type 2 Diabetes Mellitus: Focus on

*by Alpana Mukhuty, Chandrani Fouzder, Snehasis Das* 

*by Pilar Durruty, María Sanzana and Lilian Sanhueza*

*and Dipanjan Chattopadhyay*

with Type 2 Diabetes Mellitus

Pathogenesis of Type 2 Diabetes Mellitus

Cognitive Dysfunction in Diabetes Mellitus

SGLT2 Inhibitors Therapy in Type 2 Diabetes Mellitus
